Colorectal Cancer Screening in a Changing World

Robert S Bresalier

doi:10.1016/j.gtc.2022.05.002

Colorectal Cancer Screening in a Changing World

Gastroenterol Clin North Am. 2022 Sep;51(3):577-591. doi: 10.1016/j.gtc.2022.05.002. Epub 2022 Aug 30.

Author

Robert S Bresalier¹

Affiliation

¹ Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1466, Houston, TX 77030, USA. Electronic address: rbresali@mdanderson.org.

PMID: 36153111
DOI: 10.1016/j.gtc.2022.05.002

Abstract

Early detection of colorectal neoplasia significantly reduces mortality from colorectal cancer (CRC), and numerous screening options exist. Guidelines for CRC screening from US and international professional societies provide menus of options based on strength of evidence. Despite availability of screening and its proven impact, 40% of guideline-eligible patients are not screened as recommended in the United States. Adherence to or uptake of CRC screening is especially poor among underserved populations, including those with low income and African American and Hispanic populations. Consideration of screening options must not only take into account test performance, but issues of resources and individual versus population benefits.

Keywords: Artificial intelligence; Colorectal cancer screening; Early-onset colorectal cancer; Guidelines; Non-invasive screening tests; Quality colonoscopy; Underserved populations.

Publication types

Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Colonoscopy
Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / epidemiology
Colorectal Neoplasms* / prevention & control
Early Detection of Cancer*
Humans
Mass Screening
United States

Grants and funding

P30 DK056338/DK/NIDDK NIH HHS/United States